Dengue vaccine immunity study for all ages
Part of Infections clinical trials.
This study looks at how the dengue vaccine works in people with and without past exposure to dengue or similar viruses like yellow fever or Zika. Volunteers receiving the dengue vaccine will give blood samples to help researchers understand the immune response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 4 years or older.
- You are planning to get the dengue vaccine at the study clinic.
- You may or may not have had a past dengue, Zika, yellow fever, or other related virus infection or vaccine.
- You are willing to provide blood samples before and after vaccination.
- You or your parent/guardian can sign a consent form.
- No other requirements—this study is open to many people.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
This trial tests a two-dose dengue vaccine compared to the standard one-dose vaccine in children and teens who have never had dengue. It checks if the two-dose version works better and if a new manufacturing version works the same.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
This study collects blood samples from people with suspected or confirmed dengue to help improve testing. Participation may help researchers understand the disease better and could lead to better diagnostics.
Hear when a new Dengue Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.